TWC
EPRX

TD Waterhouse Canada’s Eupraxia Pharmaceuticals EPRX Stock Holding History

TD Waterhouse Canada’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$55.9K Sell
9,600
-95,386
-91% -$555K ﹤0.01% 1099
2025
Q1 		$343K Buy
+104,986
New +$343K ﹤0.01% 708
2024
Q4 		– Sell
-1,500
Closed -$3.84K – 2068
2024
Q3 		$3.84K Buy
+1,500
New +$3.84K ﹤0.01% 1544